创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06628 创胜集团-B

已收盘 04-28 15:58:52

2.240

-0.010

-0.44%

最高2.260	最低2.160	成交量86.15万
今开2.220	昨收2.250	日振幅4.44%
总市值10.08亿	流通市值10.08亿	总股本4.50亿
成交额189.93万	换手率0.19%	流通股本4.50亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06628","market":"HK","secType":"STK","nameCN":"创胜集团-B","latestPrice":2.24,"timestamp":1777363132562,"preClose":2.25,"halted":0,"volume":861500,"delay":0,"changeRate":-0.00444444444444435,"floatShares":450000000,"shares":450000000,"eps":-0.5615294550983143,"marketStatus":"已收盘","change":-0.01,"latestTime":"04-28 15:58:52","open":2.22,"high":2.26,"low":2.16,"amount":1899285,"amplitude":0.044444,"askPrice":2.26,"askSize":2000,"bidPrice":2.24,"bidSize":46000,"shortable":0,"etf":0,"ttmEps":-0.5741352183760315,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777426200000},"marketStatusCode":5,"adr":0,"listingDate":1632844800000,"exchange":"SEHK","adjPreClose":2.25,"openAndCloseTimeList":[[1777339800000,1777348800000],[1777352400000,1777363200000]],"volumeRatio":1.011373,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06628","defaultTab":"news","newsList":[{"id":"1144725402","title":"创胜集团-B2025年：营收同比下滑、亏损收窄，聚焦Claudin18.2等创新管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1144725402","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144725402?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:57","pubTimestamp":1777366625,"startTime":"0","endTime":"0","summary":"创胜集团-B于2025年在高端肿瘤及自身免疫疾病创新药物研发方面持续推进多款临床管线，核心产品osemitamab在相关适应症临床数据上取得积极进展，并计划后续展开III期注册研究。公司同时拓展多个在研项目，包括TST003、TST105、TST103及ozekibart等，覆盖单克隆抗体、双特异性抗体及RNA干扰等多种前沿技术领域。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"创胜集团-B2025年：营收同比下滑、亏损收窄，聚焦Claudin18.2等创新管线","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177856808","title":"创胜集团公布新型Liv1靶向ADC药物Tst013新数据 展现前列腺癌及ER阳性/HER2阴性乳腺癌PDX模型强效抗肿瘤活性","url":"https://stock-news.laohu8.com/highlight/detail?id=1177856808","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177856808?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:05","pubTimestamp":1776942318,"startTime":"0","endTime":"0","summary":"创胜集团近日公布其创新Liv1靶向抗体偶联药物Tst013的最新研究数据。实验结果显示，该药物在前列腺癌与ER阳性/HER2阴性乳腺癌的人源肿瘤异种移植模型中均表现出显著的抗肿瘤活性。研究采用高保真度的PDX模型验证Tst013的疗效，数据显示该ADC药物能精准识别并作用于Liv1靶点，有效抑制肿瘤生长。在两种不同癌种的模型中，Tst013均展现出剂量依赖性的肿瘤消退效果，为后续临床开发提供有力支持。此次公布的数据进一步印证了Tst013作为潜在\"first-in-class\"疗法的开发价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629079406","title":"创胜集团医药-B(06628)公布其新型LIV1 ADC TST013在前列腺癌及 ER阳性╱HER2阴性乳腺癌PDX模型中显示出强大的抗肿瘤活性的新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2629079406","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629079406?lang=zh_cn&edition=full","pubTime":"2026-04-23 07:00","pubTimestamp":1776898849,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团医药-B 公布，于2026年AACR年会上发表强调其自主研发的LIV1抗体偶联药物的临床前数据。对于LIV1表达的前列腺癌PDX模型，ADC-2在给药两剂后显示出有限的肿瘤生长抑制。总体而言，该等数据证明创胜医药的LIV1 ADC-2及ADC-3项目在ER阳性╱Her2 阴性乳腺癌以及前列腺癌的PDX模型中作为单药疗法显示出强大的抗肿瘤活性。该等结果支持进一步研究创胜医药的LIV1 ADC在LIV1阳性实体瘤中的应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","ADC","BK4080","06628","BK1574","BK1161","BK1515","PDX","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154381658","title":"创胜集团-B更新3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1154381658","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154381658?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:50","pubTimestamp":1775724658,"startTime":"0","endTime":"0","summary":"创胜集团-B于2026年4月9日公布了截至2026年3月31日止的股份变动月报表。根据公告，公司本月并未发生新增发行、股份购回或注销活动，股本状况保持稳定。于本月末，已发行股份总数449,892,499股，另有2,516,500股为库存股份，合计452,408,999股，与上个月保持一致。公司再次确认遵守香港联交所上市规则及相关法律规定。该月报表由执行董事、主席及首席执行官钱雪明签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625594521","title":"创胜集团-B(06628)拟更改中文股份简称为“创胜集团医药-B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2625594521","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625594521?lang=zh_cn&edition=full","pubTime":"2026-04-08 19:35","pubTimestamp":1775648145,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团-B(06628)发布公告，公司于香港联合交易所有限公司进行股份买卖的中文股份简称将由“创胜集团-B”更改为“创胜集团医药-B”，自2026年4月13日上午九时正起生效。公司于联交所的英文股份简称、公司名称及股份代号维持不变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06628","159938","BK1574","BK1515","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184063873","title":"异动解读 | 创胜集团-B(06628)盘中大涨5.51%，因年度业绩亏损大幅收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1184063873","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184063873?lang=zh_cn&edition=full","pubTime":"2026-03-31 10:00","pubTimestamp":1774922424,"startTime":"0","endTime":"0","summary":"创胜集团-B(06628)今日盘中大涨5.51%，引起了市场的广泛关注。消息面上，公司发布了截至2025年12月31日止年度的业绩报告。报告显示，公司年内亏损为2.04亿元人民币，较上年同期大幅收窄29.82%。尽管收入有所下降，但亏损的大幅收窄被市场解读为公司在控制成本、改善经营效率方面取得了积极进展，增强了投资者对公司未来盈利能力的信心。此次业绩改善可能是推动股价在交易时段内显著上涨的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623932018","title":"创胜集团-B(06628)发布年度业绩 年内亏损2.04亿元 同比收窄29.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623932018","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623932018?lang=zh_cn&edition=full","pubTime":"2026-03-31 07:58","pubTimestamp":1774915095,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团-B(06628)发布截至2025年12月31日止年度业绩，该集团期内取得收入743.5万元，同比减少33.98%;年内亏损2.04亿元，同比收窄29.82%;每股基本亏损0.49元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189573049","title":"创胜集团任命黄志宏博士为全球合作伙伴负责人，专注Hicb平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1189573049","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189573049?lang=zh_cn&edition=full","pubTime":"2026-03-30 20:31","pubTimestamp":1774873888,"startTime":"0","endTime":"0","summary":"创胜集团-B（Transcenta Therapeutics）近日宣布，正式任命黄志宏博士（Dr. Christopher Hwang）担任全球合作伙伴负责人，他将专注于推动公司Hicb平台的国际合作与业务拓展。\n黄志宏博士在生物医药领域拥有丰富的行业经验和深厚的专业背景，此前曾多次主导跨国药企的战略合作与授权项目。他的加入将进一步提升创胜集团在全球创新药物开发领域的合作能力，加速Hicb技术平台的国际化布局。\nHicb平台作为创胜集团的核心技术平台之一，致力于开发具有差异化优势的生物药产品。此次人事任命也反映出公司持续加强全球战略合作、推动创新疗法落地的决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618907359","title":"创胜集团-B03月11日获主力加仓22.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618907359","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618907359?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:16","pubTimestamp":1773216960,"startTime":"0","endTime":"0","summary":"03月11日, 创胜集团-B股价涨3.02%，报收2.39元，成交金额354.0万元，换手率0.32%，振幅8.19%，量比0.87。创胜集团-B今日主力资金净流入22.6万元，上一交易日主力净流入0.3万元。该股近5个交易日上涨22.56%，主力资金累计净流出133.1万元；近20日主力资金累计净流出192.0万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162131a6b78ac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162131a6b78ac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618837629","title":"创胜集团-B03月09日主力净流出149.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618837629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618837629?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:15","pubTimestamp":1773044146,"startTime":"0","endTime":"0","summary":"03月09日, 创胜集团-B股价跌5.86%，报收2.09元，成交金额777.5万元，换手率0.88%，振幅20.72%，量比3.42。创胜集团-B今日主力资金净流出149.7万元，上一交易日主力净流入11.3万元。该股近5个交易日上涨2.44%，主力资金累计净流出156.0万元；近20日主力资金累计净流出243.3万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161921a6b1b6fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161921a6b1b6fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109194841","title":"创胜集团-B（06628）2月股份变动月报：股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1109194841","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109194841?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:49","pubTimestamp":1772700589,"startTime":"0","endTime":"0","summary":"创胜集团-B于2026年3月5日发布2月股份变动月报。报告期截至2026年2月28日，公司注册股本维持10,000,000,000股普通股，每股面值USD 0.0001，注册股本总额USD 1,000,000。报告显示，截至2月末已发行股份449,892,499股，库存股2,516,500股，合计452,408,999股。当月无新增发行、购回或注销活动，股本结构保持不变。当月亦无任何股份由于激励计划被没收或失效。本次月报由执行董事、主席及首席执行官钱雪明签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617457337","title":"创胜集团-B盘中异动 快速上涨6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617457337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617457337?lang=zh_cn&edition=full","pubTime":"2026-03-05 11:22","pubTimestamp":1772680969,"startTime":"0","endTime":"0","summary":"2026年03月05日早盘11时22分，创胜集团-B股票出现异动，股价大幅拉升6.15%。截至发稿，该股报2.070港元/股，成交量25万股，换手率0.06%，振幅6.15%。创胜集团-B股票所在的生物技术行业中，整体涨幅为4.59%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305112249954313c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305112249954313c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616819353","title":"创胜集团-B03月02日主力净流出24.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616819353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616819353?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:15","pubTimestamp":1772439349,"startTime":"0","endTime":"0","summary":"03月02日, 创胜集团-B股价跌11.26%，报收2.05元，成交金额305.2万元，换手率0.32%，振幅12.12%，量比1.80。创胜集团-B今日主力资金净流出24.7万元，上一交易日主力净流出0万元。该股近5个交易日下跌14.23%，主力资金累计净流出19.3万元；近20日主力资金累计净流出149.2万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302162100a4413da4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302162100a4413da4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616886353","title":"创胜集团-B盘中异动 快速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616886353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616886353?lang=zh_cn&edition=full","pubTime":"2026-03-02 09:56","pubTimestamp":1772416597,"startTime":"0","endTime":"0","summary":"2026年03月02日早盘09时56分，创胜集团-B股票出现波动，股价快速下挫5.19%。截至发稿，该股报2.190港元/股，成交量22.45万股，换手率0.05%，振幅4.76%。创胜集团-B股票所在的生物技术行业中，整体跌幅为1.87%。其相关个股中，正大企业国际、中生北控生物科技、愉悦集团涨幅较大，振幅较大的相关个股有MIRXES-B、康诺亚-B、百奥赛图-B，振幅分别为7.19%、6.52%、6.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302095637a43fde27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302095637a43fde27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614653896","title":"创胜集团-B盘中异动 大幅拉升6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614653896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614653896?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:37","pubTimestamp":1772156271,"startTime":"0","endTime":"0","summary":"2026年02月27日早盘09时37分，创胜集团-B股票出现波动，股价急速拉升6.58%。创胜集团-B股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，创胜集团-B、药明合联、云顶新耀涨幅较大，振幅较大的相关个股有奥星生命科技、康方生物、三叶草生物-B，振幅分别为6.58%、6.38%、6.28%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227093751a4cd906a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227093751a4cd906a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613795952","title":"创胜集团-B(06628)将出席奥本海默第36届年度医疗健康生命科学大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2613795952","media":"智通财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613795952?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:34","pubTimestamp":1771922044,"startTime":"0","endTime":"0","summary":"自2025 年10月上次更新以来，本公司已续期银行融资人民币7700万元，并获得新融资人民币1500万元，且正与另外三家金融机构商讨进一步信贷额度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LABU","06628","BK4585","XBI","XLV","BK4581","BK4588","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613785041","title":"创胜集团-B盘中异动 早盘大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613785041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613785041?lang=zh_cn&edition=full","pubTime":"2026-02-23 10:34","pubTimestamp":1771814094,"startTime":"0","endTime":"0","summary":"2026年02月23日早盘10时34分，创胜集团-B股票出现波动，股价急速上涨5.17%。截至发稿，该股报2.440港元/股，成交量5.9万股，换手率0.01%，振幅7.33%。创胜集团-B股票所在的生物技术行业中，整体涨幅为2.18%。其相关个股中，云康集团、中基长寿科学、和铂医药-B涨幅较大，振幅较大的相关个股有云康集团、帝王国际投资、百奥赛图-B，振幅分别为20.00%、8.57%、7.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223103454a4bda722&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223103454a4bda722&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609379648","title":"创胜集团-B盘中异动 下午盘大幅拉升5.31%报2.380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609379648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609379648?lang=zh_cn&edition=full","pubTime":"2026-02-05 13:59","pubTimestamp":1770271177,"startTime":"0","endTime":"0","summary":"2026年02月05日下午盘13时59分，创胜集团-B股票出现波动，股价急速上涨5.31%。截至发稿，该股报2.380港元/股，成交量96.85万股，换手率0.22%，振幅9.29%。资金方面，该股资金流入74.3635万港元，流出75.863万港元。创胜集团-B股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，中国抗体-B、瑞博生物-B、维亚生物涨幅较大，振幅较大的相关个股有银诺医药-B、北海康成-B、帝王国际投资，振幅分别为20.06%、18.48%、16.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020513593897a4f798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020513593897a4f798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608182597","title":"创胜集团-B02月03日遭主力抛售14.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608182597","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608182597?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:15","pubTimestamp":1770106538,"startTime":"0","endTime":"0","summary":"02月03日, 创胜集团-B股价跌1.84%，报收2.13元，成交金额148.1万元，换手率0.16%，振幅6.45%，量比0.56。创胜集团-B今日主力资金净流出14.9万元，连续3日净流出，上一交易日主力净流出14.8万元。该股近5个交易日下跌0.47%，主力资金累计净流出61.9万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出131.6万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161904a476af0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161904a476af0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608321368","title":"创胜集团-B盘中异动 大幅跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608321368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608321368?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:25","pubTimestamp":1769999132,"startTime":"0","endTime":"0","summary":"2026年02月02日早盘10时25分，创胜集团-B股票出现波动，股价大幅下跌5.04%。截至发稿，该股报2.260港元/股，成交量14.3万股，换手率0.03%，振幅5.88%。创胜集团-B股票所在的生物技术行业中，整体跌幅为3.18%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202102532a6c83be4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202102532a6c83be4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transcenta.com","stockEarnings":[{"period":"1week","weight":-0.1758},{"period":"1month","weight":-0.1176},{"period":"3month","weight":0.0514},{"period":"6month","weight":-0.2671},{"period":"1year","weight":0.875},{"period":"ytd","weight":0.0613}],"compareEarnings":[{"period":"1week","weight":-0.0165},{"period":"1month","weight":0.039},{"period":"3month","weight":-0.0443},{"period":"6month","weight":-0.016},{"period":"1year","weight":0.1795},{"period":"ytd","weight":0.0115}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的投资控股公司。该公司的产品包括MSB2311，TST001，TST005，TST002，TST004，TST003，TST008，MSB0254和TST006。该公司还提供合同开发和生产（CDMO）服务，主要包括工艺开发服务、GMP/cGMP生产服务、细胞株开发服务、样品检测服务、配方优化服务及成药性研究。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.077034},{"month":2,"riseRate":0.2,"avgChangeRate":0.209822},{"month":3,"riseRate":0.6,"avgChangeRate":0.021801},{"month":4,"riseRate":0.4,"avgChangeRate":0.026845},{"month":5,"riseRate":0.5,"avgChangeRate":0.094228},{"month":6,"riseRate":0,"avgChangeRate":-0.103826},{"month":7,"riseRate":0.25,"avgChangeRate":0.319041},{"month":8,"riseRate":0.25,"avgChangeRate":-0.088571},{"month":9,"riseRate":0.5,"avgChangeRate":0.077791},{"month":10,"riseRate":0.2,"avgChangeRate":-0.134792},{"month":11,"riseRate":0,"avgChangeRate":-0.134628},{"month":12,"riseRate":0.2,"avgChangeRate":-0.086836}],"exchange":"SEHK","name":"创胜集团-B","nameEN":"TRANSCENTA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创胜集团-B(06628)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创胜集团-B,06628,创胜集团-B股票,创胜集团-B股票老虎,创胜集团-B股票老虎国际,创胜集团-B行情,创胜集团-B股票行情,创胜集团-B股价,创胜集团-B股市,创胜集团-B股票价格,创胜集团-B股票交易,创胜集团-B股票购买,创胜集团-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创胜集团-B(06628)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}